Canadian Thalidomide Survivors Support Program
A settlement between the Federal Government of Canada (“Canada”) and Bruce Wenham of Toronto, Ontario (the “Representative Applicant”) has been approved by the Federal Court and is now final. Please click here for more information.
September 1, 2021
The Administrator has received questions from confirmed survivors asking how determinations are made as to whether someone receives funding or not, including instances where two individuals have requested the funding for a similar type of expense.
The majority of EMAF funding requests received are approved, but are subject to the guiding principles, which are outlined in the annual letter sent to Confirmed Survivors and are available on the FAQs page of this website.
When reviewing requests for funding to the EMAF, the Administrator does not compare one person’s application to another person’s application because no two individuals have exactly the same thalidomide-related injuries and/or exactly the same functional challenges in relation to those injuries. The Administrator carefully reviews a request for funding with respect to how the item(s) requested will provide clear health benefits as they relate to that person’s unique thalidomide-related medical condition(s), which will also help the person age with dignity.
To facilitate the Administrator’s assessment, it is very helpful when submitting your EMAF application if you can provide a brief explanation as to which aspect of your thalidomide-related condition the requested item will support. This explanation can be a personal narrative with specific reference to the physical or functional challenge and/or if you prefer, you may provide a medical practitioner’s report citing the benefit of the item.
The schedule of potentially eligible expenses found on the FAQs page of the website is shared as an aid to Survivors who may be uncertain of what expenses may be considered as eligible by the Administrator but is not all inclusive. The Administrator encourages all Survivors to submit EMAF Applications for any expense that they feel will enhance their ability to age with dignity with respect to their thalidomide-related injuries or functional challenges.
The Administrator is currently working on updating the EMAF application process and website content to better enhance to the EMAF. Further details to follow.
The next update will be on October 1, 2021.
August 1, 2021
For applicants who are currently completing their Step 2 – Probability Assessment Application forms, we highly recommend that the application be completed with the assistance of your medical practitioner. The questions asked on the Step 2 – Probability Assessment Application directly correlate to the questions that the medical assessors need to answer on the diagnostic algorithm, therefore having your medical practitioner complete the medical questionnaire and providing supporting medical documentation such as medical records, x-rays and scans will enable the medical assessors to answer the questions accurately and more efficiently.
The next status update will be September 1, 2021.
July 1, 2021
In response to Survivor feedback received in the most recent Outreach Survey, a quick link to the EMAF Schedule of Potential Eligible Expenses can be found on the FAQ page.
Please note that that the list is not all inclusive so please submit an EMAF application even if your service or item is not listed.
If you are unsure how to apply for the EMAF, we are here to help. Please call us at 1-877-507-7706 and we will help you fill out the application.
The next status update will be August 1, 2021.
Frequently asked questions and answers pertaining to the application process for Unconfirmed Claimants have added to the FAQ Page of the website.
If you have additional questions, please feel free to contact the Administrator.
The next status update will be September 1, 2019.